Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | TSPO | P30536 | 3/20 | 0.39 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | GFER | P55789 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 3/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17906206 | 0.96 | KDM4E (0.43) | KDM4EATML3MBTL1TSPOPTGER4 | |
| SCHEMBL17906203 | 0.95 | KDM4E (0.44) | KDM4EATML3MBTL1TSPOPTGER4 | |
| SCHEMBL19742297 | 0.95 | KDM4E (0.44) | KDM4EATML3MBTL1TSPOPTGER4 | |
| SCHEMBL24221816 | 0.89 | L3MBTL1 (0.50) | KDM4EATML3MBTL1TSPOPTGER4 | |
| SCHEMBL18802653 | 0.89 | L3MBTL1 (0.50) | KDM4EATML3MBTL1TSPOPTGER4 | |
| SCHEMBL14032828 | 0.89 | L3MBTL1 (0.53) | KDM4EATML3MBTL1TSPOPTGER4 | |
| SCHEMBL16557332 | 0.88 | L3MBTL1 (0.49) | KDM4EATML3MBTL1TSPOPTGER4 | |
| SCHEMBL22778273 | 0.88 | GFER (0.41) | KDM4EATML3MBTL1GAAGFER | |
| SCHEMBL14755947 | 0.88 | L3MBTL1 (0.51) | KDM4EATML3MBTL1TSPOPTGER4 | |
| SCHEMBL20736845 | 0.88 | L3MBTL1 (0.51) | KDM4EATML3MBTL1TSPOPTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3475995-B1 | QUANTUM DOT LIGHT EMITTING DEVICES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-12-21 | — | — | EP | disclosed |
| US-11367835-B2 | Quantum dot light emitting devices | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-06-21 | — | — | US | disclosed |
| US-10818860-B2 | Quantum dot light emitting devices | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2020-10-27 | — | — | US | disclosed |
| US-20200185604-A1 | COMPOSITION CONTAINING AMINIUM RADICAL CATION | DOW GLOBAL TECHNOLOGIES LLC | 2020-06-11 | — | — | US | disclosed |
| US-20200052218-A1 | QUANTUM DOT LIGHT EMITTING DEVICES | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2020-02-13 | — | — | US | disclosed |
| US-20190334106-A1 | QUANTUM DOT LIGHT EMITTING DEVICES | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2019-10-31 | — | — | US | disclosed |
| US-20190252618-A1 | COMPOSITION CONTAINING AMINIUM RADICAL CATION | DOW GLOBAL TECHNOLOGIES LLC | 2019-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200185604-A1 | COMPOSITION CONTAINING AMINIUM RADICAL CATION | SSR4, DRD4, SLC7A5 | KDM4E 2746/4885ATM 1734/4885L3MBTL1 933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.